Has Kailash Pant received payments from drug or device companies?

Yes. Drug and device makers reported $10,650 in general payments to Kailash Pant across 109 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Kailash Pant did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Kailash Pant come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Kailash Pant

Interventional Cardiology · Deland, FLNPI 1558857110

Payments from drug & device makers

$10,650in general payments, 2019–2025

Across 109 payments — averaging $97.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abbott$4K
Abiomed$2K
Edwards Lifesciences$2K
Johnson & Johnson$659
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$543
Medtronic$275
plus $1K from 17 others

What the payments were for

Travel & lodging$4,51642%
Food & beverage$6,06557%
Education$701%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abbott	33	$4,086
Abiomed	14	$2,048
Edwards Lifesciences	14	$1,666
Johnson & Johnson	8	$659
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	10	$543
Medtronic	4	$275
Shockwave Medical, Inc	2	$145
Livanova USA, Inc.	2	$133
Penumbra, Inc.	1	$129
Intuitive Surgical	1	$117
Boehringer Ingelheim	1	$114
Philips North America LLC	1	$113
Teleflex LLC	1	$96
Getinge USA Sales, LLC	4	$85
Biosense Webster, Inc.	1	$83
Novo Nordisk	1	$82
E.r. Squibb & Sons, L.L.C.	1	$76
Pfizer	3	$58
Novartis	2	$45
Cordis US CORP.	2	$36
Bayer	1	$26
Amgen	1	$17
Kestra Medical Technology Services, Inc.	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,650 in reported general payments places this provider in the 50th percentile of 623 interventional cardiology providers in Florida.

See all interventional cardiology providers in Florida →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
BrilintaTicagrelor	17	$15,060
ClopidogrelClopidogrel Bisulfate	58	$844
Metoprolol Succinate	17	$167
Spironolactone	16	$101

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Deland

Dominick AngiolilloJacksonville$4M
Douglas SpriggsClearwater$3.2M
Rakesh PrashadOcala$3.1M
Aldo Martinez FleitesMiami Lakes$2.2M
Rohit AminPensacola$2M
Roberto CubedduNaples$2M
Arthur LeeGainesville$2M
Ruby SatpathyJacksonville$1.8M
Santhosh MathewsBradenton$1.7M
Pedro Martinez-ClarkMiami$1.7M

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →